Government consults on UK value-based pricing
December 17, 2010Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing
The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …
Merck KGaA appoints new head of pharma
December 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing
Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Government pushes on with major NHS reforms
December 16, 2010GP consortia, Health and Wellbeing Boards, NHS, NHS Commissioning Board, NHS Operating Framework, NHS reforms, PCTs
The government has set out a roadmap for its wide-ranging NHS reform plans that promises no let up in the …
Reforms are a ‘risky business’ for the NHS
December 16, 2010Civitas, GP commissioning, NHS, NHS reforms, PCTs
The government is taking a ‘big risk’ with NHS reforms that will hand GPs responsibility for commissioning services, according to …
Novo rebuked after diabetes promotion breaches Code
December 16, 2010Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly
Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …
Race on to find new Johnson & Johnson leader
December 16, 2010Sales and Marketing Johnson & Johnson, recruitment
Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …
Digital Pharma: Doing good in healthcare
December 15, 2010Medical Communications Digital Pharma blog, Dose of Digital, Healthy Thinkers, corporate responsibility
A new online community has been launched to bring together suggestions for improving healthcare and the altruistic side of those …
Novartis becomes global eye health leader as Alcon deal finalised
December 15, 2010Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology
Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
Patient deaths halt Lilly cancer trial
December 15, 2010Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam
Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D
December 15, 2010Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development
Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Publicis makes German digital healthcare acquisition
December 15, 2010Medical Communications Digital District, Publicis Groupe, Publicis Healthware International, healthcare communications agency, medical communications, publicis
The healthcare arm of French communications giant Publicis Groupe has bought a German agency specialising in digital health comms to …
NHS cuts will push health service “to the limit”
December 14, 2010Health Select Committee, King’s Fund, NHS, NHS Confederation, NHS reforms, king's fund, social services
MPs have issued a stark warning on the impact of Government spending plans on the England’s health services, saying they …
Bayer invests 35m euros in biologics production
December 14, 2010Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production
Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …
GSK buys sports nutrition company for £162m
December 14, 2010Sales and Marketing GSK, GlaxoSmithKline, Maximuscle, Maxinutrition, consumer healthcare, sports nutrition
GlaxoSmithKline has acquired UK sports nutrition firm Maxinutrition for £162 million to help broaden its consumer portfolio. The company already …
Pfizer withdraws hypertension drug Thelin
December 14, 2010Sales and Marketing PAH, Pfizer, Thelin, liver damage, liver toxicity, patient safety, pulmonary arterial hypertension, sitaxentan
Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …
McNeil recalls Rolaids on particle contamination
December 14, 2010Manufacturing and Production J&J, JJ, McNeil, Rolaids, particulate contamination, pharmaceutical manufacturing, product recalls
Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …
Sopharma breaks ground on 16th manufacturing plant
December 14, 2010Manufacturing and Production Bulgaria, Sopharma, oral dosage forms, pharma manufacturing, pharmaceutica production
Bulgarian drugmaker Sopharma says it will press ahead with plans to build a new production plant for oral dosage forms …
Sanofi extends Genzyme share deal deadline
December 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
Amgen and Actelion meet to “talk takeover”
December 13, 2010Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover
Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
Novartis pulls Zometa submission after breast cancer failure
December 13, 2010Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic
Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
